UK markets closed

Zomedica Pharmaceuticals Corp. (ZOM)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.1330+0.0029 (+2.23%)
At close: 04:00PM EDT
0.1338 +0.00 (+0.60%)
After hours: 07:56PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
16,854
25,186
18,930
4,133
0
Cost of revenue
4,435
7,868
5,462
1,079
0
Gross profit
12,419
17,318
13,468
3,054
0
Operating expenses
Research development
2,466
5,744
2,578
1,673
8,044
Selling general and administrative
32,499
43,166
32,813
22,755
8,721
Total operating expenses
34,971
48,910
35,391
24,428
16,765
Operating income or loss
-22,552
-31,592
-21,923
-21,374
-16,765
Interest expense
175
175
1
6
0.732
Total other income/expenses net
-79.62
-9,551
-158
306
-178.933
Income before tax
-21,146
-35,860
-19,381
-20,717
-16,912
Income tax expense
-3,650
-1,331
-2,366
-2,333
0
Income from continuing operations
-17,496
-34,529
-17,015
-18,384
-16,912
Net income
-17,496
-34,529
-17,015
-18,384
-16,912
Net income available to common shareholders
-17,496
-34,529
-17,015
-50,423
-16,912
Basic EPS
-0.02
-
-0.02
-0.05
-0.05
Diluted EPS
-0.02
-
-0.02
-0.05
-0.05
Basic average shares
979,924
-
979,950
956,534
364,445
Diluted average shares
979,924
-
979,950
956,534
364,445